Lunesta FDA Approval History
FDA Approved: Yes (First approved December 15, 2004)
Brand name: Lunesta
Generic name: eszopiclone
Dosage form: Tablets
Previous Name: Estorra
Company: Sepracor Inc.
Treatment for: Insomnia
Lunesta (eszopiclone) is a nonbenzodiazepine hypnotic agent indicated for the treatment of patients who experience difficulty falling asleep as well as for the treatment of patients who are unable to sleep through the night (sleep maintenance difficulty).
Development timeline for Lunesta
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.